Featured for The Business Fame’s issue of The Fastest Growing Companies to Admire in 2022 is R3 Stem Cell, a company dedicated to repairing, regenerating and restoring injured tissue with regenerative therapies to provide an improved quality of life for individuals around the world.
The Company-
R3 offers therapies that harness the body’s regenerative capabilities to bring patients hope and options. Hope that surgery can be avoided, and tissue injury can be repaired with the ability do things like play with your kids again, go hiking, swimming, ride a bike and be… Pain Free!
Existing pain management therapies have been great for suppressing pain by masking discomfort with medications such as cortisone, opiates or anti-inflammatory medications.
These treatments work well for relief, but they don’t actually FIX the PROBLEM! It’s like placing a Band-Aid over the issue, but the underlying painful issue remains.
R3 Stem Cell is the only US company to have achieved Institutional Review Board Approval for the investigation of regenerative therapies with amniotic and umbilical cord tissue for several condition categories.
R3 Centers of Excelence offers stem cell and exosome procedures including:
- Stem Cell Injections derived from your own Bone Marrow or Fat or Amniotic Derived Injections processed at an FDA Regulated Lab
- Platelet Rich Plasma Therapy
- Umbilical Cord Tissue with growth factors, exosomes, cytokines and stem cells.
These are all outpatient therapies, some of which are accompanied with hyperbaric oxygen therapy, nutritional counselling, supplements, shock wave therapy and laser treatments.
All of the therapies at R3 are administered by providers who are compassionate and highly skilled.
The Key Differentiators-
One of the key differentiators with R3’s stem cell biologic is due to the IntelliCell. Years of research allowed R3 to identify the “smart” stem cells in a batch, and then expand those. Patients then receive these IntelliCell, which allows for the best possible outcome possible. No other regenerative company has been able to perform this feat.
A couple years ago, R3 created the Stem Cell Master Class for patients and their loved ones. It’s an eight-episode series that is free where they can learn all about the procedures, biologics and options. In addition, R3 created R3 Medical Training for providers. The courses allow providers to learn all about musculoskeletal and aesthetics procedures in a hands-on setting with expert trainers and real patients.
The Road Ahead-
A few years, R3 expanded into Mexico and Pakistan. The international expansion has worked out very well, as patients around the world are seeing tremendous quality of life improvements from the treatments. The company has continued to expand around the world, with India and the Philippines coming on board.
According to founder Dr. Greene, “It’s not just Americans who should benefit from regenerative therapies, but individuals from around the world. So R3 is the company that will be bringing this amazing technology to many countries as the years go by to make it more readily available!”
In addition R3 has several clinical trials starting in 2022 to achieve regulatory milestones. Conditions include autism, arthritis, erectile dysfunction and opiate addiction.
David Greene- Leading the Way!
Founder
For over a decade, R3 Stem Cell has been at the forefront of regenerative medicine. This includes providing first rate regenerative therapies and comprehensive education to patients globally, along with unparalleled hands on training to providers desiring to learn the procedures.
Founder David Greene, MD, PhD, MBA, began the company during his time at the WP Carey School of Business at Arizona State University in 2012. The company has grown to over 45 locations in six countries, with over 18,000 stem cell procedures having been performed in that time!
David’s Message to the Budding Entrepreneurs-
“Time and time again, we see entrepreneurs who are looking to make a “quick buck” by entering the industry recklessly. This may include faulty science, a shoddy product and/or false promises to patients and providers.
For those who want to enter the industry properly, the first advice is to not waver from ethical principles. This is new technology and it’s amazing, but stem cell therapy does not provide a cure. So make sure not to overpromise, and make sure to become educated about what you are offering. Providers and patients do NOT like to receive inaccurate information and unrealistic expectations.
Another piece of advice is to expect regular changes in the industry. Be amenable to pivoting strategy when necessary. For instance, what do you do if you enter the regenerative space in a country and all of a sudden that country implements new stem cell regulations? You need to stay on top of it and react appropriately.”
